Contents Link Navigation Link
OUR PIPELINE

Targeting, Attacking, Eradicating Cancer

Development Pipeline

Targeting, Attacking, Eradicating Cancer

SillaJen, Inc. designs, engineers and develops potent multi-functional immunotherapeutics for cancer. These best-in-class products from the solve platform, are vaccinia viruses engineered for 1) cancer cell selectivity, 2) acute replication and cancer cell lysis and 3) generation of a durable cancer-specific immune response.

Lead Product
Lead Product
JX-594 wyeth TK- GM-CSF
Candidate
Candidate
SJ-102 wyeth TK-
SJ-103 western reserve TK-
SJ-815 western reserve TK- CE2+ IFNβ+
JX-929 western reserve TK- VGF- yCD+ hSSTR2+
JX-930 western reserve TK- yCD+ VGF-
JX-963 western reserve TK- GM-CSF
JX-970 western reserve TK- VGF- GM-CSF
 
  • western reserve TK- VGF-
  • western reserve TK- IFNβ+
  • western reserve CES2+
  • western reserve CES1m6+
  • Copenhagen CES1m6+
  • western reserve TK- B18R-
  • western reserve A34R K151E TK-
JX-594JX-594
JX-929JX-929
SJ-815SJ-815